Market brief — October 9, 2026

Yesterday, Thursday October 8, markets closed lower as an inflationary rates-and-energy shock extended across Europe and the United States: the CAC 40 fell 0.51% to 7,729.69, the S&P 500 declined 0.47% to 7,765.36, the Nasdaq dropped 1.25% to 27,193.34, the DAX fell 1.18% to 24,806.97, and the Euro Stoxx 50 lost 0.87% to 6,126.73. The move was primarily a discretionary duration unwind, amplified by systematic selling in long-duration technology, rather than indiscriminate liquidation. Brent settled near $104.28 after rising roughly 4.1%, while the U.S. 10-year yield reached approximately 5.35% intraday before retreating after firm demand at the 30-year Treasury auction.^[1][3][5][6]

The dominant regime remains inflationary duration stress: oil above $100 is lifting inflation risk premiums while high long-end yields challenge equity valuations. The key divergence is that yields eased after the auction even as oil remained elevated, suggesting bond-market demand has not disappeared but is becoming highly price-sensitive. Today’s relief in oil—Brent was reported around $103 after President Donald Trump said the United States would not attack Iran before the November midterm elections—could support a tactical rebound, but it does not remove the shipping and supply-disruption premium.^[6][9] Positioning therefore favors selective de-risking rather than a wholesale macro capitulation; the next move will depend on whether the 10-year yield can hold below the recent 5.3% area.

The Cash Scanner shows that leadership remains concentrated in U.S. momentum and defensive-growth exposures, not in broad European cyclicals. Palantir (PLTR) leads with a score of 41 and a 2.4% gap, supported by a 20-day breakout, rising volume and ADX at 31. DXC Technology (DXC), score 39 and gap +2.9%, carries the same breakout-and-volume profile, while Okta (OKTA), score 35 and gap +1.0%, combines ADX 43 with rising KST. Healthcare adds selective resilience: Doximity (DOCS), score 35 and gap +6.1%, shows a 20-day breakout and ADX 33. Philip Morris International (PM), score 34 and gap +4.1%, reinforces the defensive-income rotation through a breakout, volatility squeeze and rising volume. The concentration in four technology names and two biotechnology names confirms stock-specific momentum, but the presence of tobacco, healthcare and real estate indicates investors are seeking duration substitutes rather than simply adding beta.

Over the next one to five sessions, markets are most likely to trade the conflict between easing Treasury pressure and persistent oil-driven inflation. Consensus increasingly expects elevated energy prices to delay monetary easing; much of the immediate shock is already priced into technology underperformance and the 5.3% 10-year yield zone. Less fully priced is the second-order effect on inflation expectations, consumer purchasing power and corporate margins if Brent remains above $100. A credible contrarian scenario is a sustained oil pullback toward the low-$90s combined with stable Treasury auctions, which could trigger short covering in the Nasdaq and revive high-beta software momentum.

The highest-impact catalysts are Friday’s U.S. Michigan consumer survey and one-year inflation expectations, which could either validate renewed inflation concerns or support a duration rebound.^[8] ECB Executive Board member Isabel Schnabel’s remarks are also relevant for European rates and banks.^[8] Over the weekend, developments around the Strait of Hormuz and further U.S.-Iran signaling will determine whether the oil risk premium extends into next week; any attack on shipping or energy infrastructure would invalidate the relief narrative. The coming U.S. earnings season remains the broader test of whether high yields are merely compressing multiples or beginning to damage demand and guidance.^[1][5]

The principal risks are a renewed Treasury sell-off if inflation expectations rise despite softer growth, a failed auction or liquidity deterioration at the long end, and a fresh geopolitical escalation that sends Brent toward the $110–$120 scenario discussed by Goldman Sachs.^[9] A separate risk is that weak consumer expectations combine with high fuel costs, producing stagflationary pressure rather than a clean inflation shock.

Actionably, a sustained 10-year yield below roughly 5.23% after the auction-driven retreat would favor a tactical Nasdaq recovery and continuation in Palantir, Okta and DXC; a move back above 5.30% would invalidate that setup. Brent holding below $103 would support short covering in technology and real estate, including Host Hotels & Resorts (HST), while a return above $105 would favor Philip Morris International and healthcare over long-duration growth. Finally, monitor whether the Nasdaq stabilizes after its 1.25% fall: stabilization alongside declining yields confirms a positioning unwind, whereas renewed weakness with oil above $105 signals genuine macro repricing.

Bonne journée aux p&l makers.